Y'all failed to convince me. My Jan 20, 2023 long call options at the 60 strike are up 8.34% or $409 so far. Wish me continued luck!
AARRGG ! ! ! If only I'd seen the post in time, I could've convinced you not to do it! ! ! ! !
Here's my take:
1) Congratulations on the winning trade (so far). You're up and that's always a great place to be on a trade.
2) The easy money has already been made.
3) The time to gamble on new drugs is when they're still in the pipeline, before Phase II is finished. Once they complete Phase II, the stock will react according to the results. Phase III is generally a snoozer, just a repeat of Phase II. But, it's not over until it's over, so the final 'easy' bump will be after the FDA approval. The FDA approval can take much longer after Phase III completion than anyone thinks is necessary, so it's not to be discounted.
Since NVO has already gotten FDA approval, I'm kinda with Malcat on this. It's not a sure thing and the stock has already gotten it's FDA approval bounce.
4) What else does NVO have in it's pipeline? There might be something of interest there that could move the stock. Which, by the way, leads to
5) It's already a huge company, market cap of $140 billion. So, it's going to take a lot to move the needle on that stock.
6) Let us know how the trade pans out for you. Inquiring minds want to know.